ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 218476 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 218476; 2) Community: the network communities that were significantly associated with the response to NSC 218476; 3) Molecule: the relationships between components within communities and NSC 218476; 4) MDR: the compounds that were significantly associated with the NSC 218476.

NSC Compound Enrichment Correlation
NSC 656208 Null 0.00397405528023199 0.55341144
NSC 66214 4-Amino-1-dodecylquinaldinium acetate 0.00397405528023199 0.28235466
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.00397405528023199 0.51023298
NSC 706190 6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- 0.00397405528023199 0.48564736
NSC 709971 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazol-7-one, 4,6-dibromo-1,2,3a,7a-tetrahydro-2-thioxo-, CIS- 0.00397405528023199 0.62835725
NSC 19441 FDA 0283 0.0041574867185751 0.080798722
NSC 92585 Benzoic acid, p-[(purin-6-ylthio)mercuri]- 0.00415748671857519 0.53096381
NSC 114346 Null 0.00426229108513041 0.42826097
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.00426229108513044 0.45942803
NSC 633514 Null 0.00426229108513044 0.46149
Total:84  Current:12    [First] [Prev] [Next] [Last]